ClinicalTrials.Veeva

Menu

Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days

Alcon logo

Alcon

Status

Completed

Conditions

Dry Eye

Treatments

Other: Systane® Ultra

Study type

Interventional

Funder types

Industry

Identifiers

NCT00946777
SMA-09-04

Details and patient eligibility

About

The primary objective is to determine if there is a correlation between reductions in corneal staining and improvements in corneal barrier function.

Enrollment

19 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients must have moderate corneal staining and exhibit a need to use artificial tears.

Exclusion criteria

  • Patients can not participate in any other ophthalmic drug or device clinical trial within 30 days of the baseline visit.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

19 participants in 1 patient group

Systane® Ultra
Experimental group
Treatment:
Other: Systane® Ultra

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems